Oh, T. G., Bailey, P., Dray, E., Smith, A. G., Goode, J., Eriksson, N., . . . Muscat, G. E. O. (2014). PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes. Mol Endocrinol.
Chicago-tyylinen lähdeviittausOh, Tae Gyu, et al. "PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes." Mol Endocrinol 2014.
MLA-viiteOh, Tae Gyu, et al. "PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes." Mol Endocrinol 2014.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.